PROMIDIS is a privately-owned company focused on the identification of innovative drugs in high, unmet, medical-need areas. The Company was incubated in the IRBM Science Park of Pomezia and later relocated to the San Raffaele Hospital Science Park (SRSI) in Milan, one of Italy’s largest research hospitals, as well as an internationally recognized center of excellence for biomedical research. PROMIDIS aims to create an innovative portfolio of drug discovery projects, joining the cutting-edge preclinical and clinical research activities taking place at the SRSI for a variety of human diseases.
PROMIDIS currently employs over 15 experienced researchers with recognized competence in drug discovery in areas such as CNS, antivirals, oncology and infectious diseases. In addition to its proprietary drug discovery projects, PROMIDIS offers specialty services for integrated drug discovery in partnership with us, including process chemistry activities such as chemical route identification and optimization, scale-up processes, detection and characterization of impurities.